Home › Companies › KURA ONCOLOGY INC. › 2024-2025

KURA ONCOLOGY INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and KURA ONCOLOGY INC.’s Form 8-K, filed 2025-06-06 (Item 5.07 on EDGAR). Page generated 02 October 2026.

7Ballot items
184Asset managers
1,226Fund votes
2025-06-05Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore KURA ONCOLOGY INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by KURA ONCOLOGY INC.

These tallies are KURA ONCOLOGY INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-06 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

KURA ONCOLOGY INC. — official shareholder meeting results, meeting held 2025-06-05
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Helen Collins, M.D.	55,377,590	--	--	9,392,655	5,864,331	Majority: yes
Elect Director: Thomas Malley	53,300,572	--	--	11,469,673	5,864,331	Majority: yes
Elect Director: Carol Schafer	55,407,228	--	--	9,363,017	5,864,331	Majority: yes
Proposal 2. Ratification of the Appointment of Independent Registered Public Accounting Firm	70,490,630	72,936	71,010	--	--	Majority: yes
Proposal 3. Advisory Vote on Executive Compensation	63,155,796	1,522,754	91,695	--	5,864,331	Majority: yes
Proposal 4. Approval of our Amended 2014 Plan	53,050,063	11,634,755	85,427	--	5,864,331	Majority: yes

Source: KURA ONCOLOGY INC., Form 8-K, filed with the SEC on 2025-06-06 — read the filing on EDGAR.

How asset managers voted at the KURA ONCOLOGY INC. 2024-2025 meeting

Each item below shows how the 184 asset managers that disclosed a KURA ONCOLOGY INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the proxy statement.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-06-05.

Combines 6 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 63,155,796AGAINST: 1,522,754

KURA ONCOLOGY INC.’s own tally for this item (“Proposal 3. Advisory Vote on Executive Compensation”): 63,155,796 for, 1,522,754 against, per its Form 8-K filed 2025-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 80,778,000 outstanding shares: 78% for, 2% against (80% of the company cast a for/against vote).

The 181 asset managers below cast 99.2% of the shares they voted on this item FOR (61,330,436 for, 480,143 against).

FOR 99.1%

FOR: 61,330,436 (99.2%)AGAINST: 480,143 (0.8%)ABSTAIN: 8,319 (0.0%)NOT VOTED: 8,992 (0.0%)

Largest asset managers voting on “Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the proxy” at KURA ONCOLOGY INC., 2024-2025
Asset manager	For	Against	Vote
BVF INC/IL	7,754,129	0	For
SUVRETTA CAPITAL MANAGEMENT, LLC	7,452,388	0	For
BlackRock	7,313,139	38,150	For
ARMISTICE CAPITAL, LLC	6,027,476	0	For
Vanguard	5,041,378	0	For
State Street	4,715,126	1,040	For
RA CAPITAL MANAGEMENT, L.P.	3,957,637	0	For
GEODE CAPITAL MANAGEMENT, LLC	1,808,302	0	For
Fidelity	1,643,981	0	For
FRANKLIN ADVISERS INC	1,362,871	0	For
Charles Schwab	1,245,944	0	For
JACOBS LEVY EQUITY MANAGEMENT, INC	1,076,441	0	For
Dimensional	879,647	0	For
FRANKLIN STRATEGIC SERIES	761,091	0	For
TCG Crossover Management, LLC	735,184	0	For
Prosight Management, LP	599,124	0	For
Northern Trust	588,315	0	For
Sofinnova Investments, Inc.	498,846	0	For
Foresite Capital Management IV, LLC	498,015	0	For
DAFNA Capital Management LLC	463,368	0	For
SILVERARC CAPITAL MANAGEMENT, LLC	463,065	0	For
1492 Capital Management LLC	399,803	0	For
JPMorgan	344,493	0	For
AQR	334,650	0	For
Russell Investments	283,492	0	For

Showing the 25 largest of 181 asset managers. See all 181 in the interactive database.

2. APPROVAL OF AN AMENDMENT TO OUR AMENDED AND RESTATED 2014 EQUITY INCENTIVE PLAN.

COMPENSATIONMajority of the votes cast: yes

Meeting held 2025-06-05.

Combines 2 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%AGAINST 18%

FOR: 53,050,063AGAINST: 11,634,755

KURA ONCOLOGY INC.’s own tally for this item (“Proposal 4. Approval of our Amended 2014 Plan”): 53,050,063 for, 11,634,755 against, per its Form 8-K filed 2025-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 80,778,000 outstanding shares: 66% for, 14% against (80% of the company cast a for/against vote).

The 57 asset managers below cast 88% of the shares they voted on this item FOR (14,259,417 for, 1,912,821 against).

FOR 88%12%

FOR: 14,259,417 (88.1%)AGAINST: 1,912,821 (11.8%)ABSTAIN: 8,319 (0.1%)

Largest asset managers voting on “APPROVAL OF AN AMENDMENT TO OUR AMENDED AND RESTATED 2014 EQUITY INCENTIVE PLAN.” at KURA ONCOLOGY INC., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	4,858,902	0	0	For
BlackRock	3,761,831	0	0	For
Fidelity	1,638,027	800	0	For
State Street	1,618,632	1,866	0	For
FRANKLIN STRATEGIC SERIES	761,091	0	0	For
Dimensional	0	684,977	0	Against
Charles Schwab	622,972	0	0	For
TIAA	0	233,167	0	Against
ALGERT GLOBAL LLC	216,458	0	0	For
Equitable	117,367	83,100	0	For
Exchange Place Advisors Trust	193,488	0	0	For
Prudential/PGIM	0	145,402	0	Against
QUANTITATIVE MASTER SERIES LLC	125,392	0	0	For
Lincoln Financial	77,446	47,045	0	For
Putnam	0	95,013	0	Against
PACE SELECT ADVISORS TRUST	0	72,226	0	Against
American Century	0	68,322	0	Against
MASTER INVESTMENT PORTFOLIO	62,429	0	0	For
Northern Trust	0	47,274	0	Against
Brighthouse	0	37,874	8,319	Against
Direxion Shares ETF Trust	0	44,590	0	Against
ProShares	0	44,546	0	Against
Global X	43,592	0	0	For
Voya	0	39,685	0	Against
PFM Multi-Manager Series Trust	0	39,024	0	Against

Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.

3. Election of three Class II directors for three-year terms: Carol Schafer

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-05.

Combines 3 wordings of this item as funds reported it.

86% Majority: yes · of votes cast

FOR 86%WITHHELD 14%

FOR: 55,407,228WITHHELD: 9,363,017

KURA ONCOLOGY INC.’s own tally for this item (“Elect Director: Carol Schafer”): 55,407,228 for, 9,363,017 withheld, per its Form 8-K filed 2025-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 80,778,000 outstanding shares: 69% for, 12% withheld (80% of the company cast a for/withheld vote).

The 56 asset managers below cast 100% of the shares they voted on this item FOR (12,948,659 for, 0 against).

FOR 81%ABSTAIN 19%

FOR: 12,948,659 (81.1%)ABSTAIN: 3,015,440 (18.9%)

Largest asset managers voting on “Election of three Class II directors for three-year terms: Carol Schafer” at KURA ONCOLOGY INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	4,858,902	0	For
BlackRock	3,761,831	0	For
Fidelity	1,638,027	800	For
State Street	1,618,632	1,866	For
FRANKLIN STRATEGIC SERIES	0	761,091	Abstain
Dimensional	0	684,977	Abstain
Charles Schwab	0	622,972	Abstain
TIAA	233,167	0	For
Equitable	117,367	83,100	For
Exchange Place Advisors Trust	0	193,488	Abstain
Prudential/PGIM	134,347	11,055	For
QUANTITATIVE MASTER SERIES LLC	125,392	0	For
Lincoln Financial	77,446	47,045	For
Putnam	95,013	0	For
PACE SELECT ADVISORS TRUST	0	72,226	Abstain
American Century	0	68,322	Abstain
MASTER INVESTMENT PORTFOLIO	62,429	0	For
Northern Trust	47,274	0	For
Brighthouse	0	46,193	Abstain
Direxion Shares ETF Trust	0	44,590	Abstain
ProShares	0	44,546	Abstain
Global X	0	43,592	Abstain
Voya	39,685	0	For
PFM Multi-Manager Series Trust	0	39,024	Abstain
Harbor ETF Trust	37,944	0	For

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.

4. Election of three Class II directors for three-year terms: Helen Collins, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-05.

Combines 3 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%WITHHELD 15%

FOR: 55,377,590WITHHELD: 9,392,655

KURA ONCOLOGY INC.’s own tally for this item (“Elect Director: Helen Collins, M.D.”): 55,377,590 for, 9,392,655 withheld, per its Form 8-K filed 2025-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 80,778,000 outstanding shares: 69% for, 12% withheld (80% of the company cast a for/withheld vote).

The 56 asset managers below cast 100% of the shares they voted on this item FOR (12,948,731 for, 0 against).

FOR 81%ABSTAIN 19%

FOR: 12,948,731 (81.1%)ABSTAIN: 3,015,368 (18.9%)

Largest asset managers voting on “Election of three Class II directors for three-year terms: Helen Collins, M.D.” at KURA ONCOLOGY INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	4,858,902	0	For
BlackRock	3,761,831	0	For
Fidelity	1,638,027	800	For
State Street	1,618,632	1,866	For
FRANKLIN STRATEGIC SERIES	0	761,091	Abstain
Dimensional	0	684,977	Abstain
Charles Schwab	0	622,972	Abstain
TIAA	233,167	0	For
Equitable	117,367	83,100	For
Exchange Place Advisors Trust	0	193,488	Abstain
Prudential/PGIM	134,347	11,055	For
QUANTITATIVE MASTER SERIES LLC	125,392	0	For
Lincoln Financial	77,446	47,045	For
Putnam	95,013	0	For
PACE SELECT ADVISORS TRUST	0	72,226	Abstain
American Century	0	68,322	Abstain
MASTER INVESTMENT PORTFOLIO	62,429	0	For
Northern Trust	47,274	0	For
Brighthouse	0	46,193	Abstain
Direxion Shares ETF Trust	0	44,590	Abstain
ProShares	0	44,546	Abstain
Global X	0	43,592	Abstain
Voya	39,685	0	For
PFM Multi-Manager Series Trust	0	39,024	Abstain
Harbor ETF Trust	37,944	0	For

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.

5. Election of three Class II directors for three-year terms: Thomas Malley

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-06-05.

Combines 3 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%WITHHELD 18%

FOR: 53,300,572WITHHELD: 11,469,673

KURA ONCOLOGY INC.’s own tally for this item (“Elect Director: Thomas Malley”): 53,300,572 for, 11,469,673 withheld, per its Form 8-K filed 2025-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 80,778,000 outstanding shares: 66% for, 14% withheld (80% of the company cast a for/withheld vote).

The 56 asset managers below cast 100% of the shares they voted on this item FOR (12,848,871 for, 0 against).

FOR 80%ABSTAIN 20%

FOR: 12,848,871 (80.5%)ABSTAIN: 3,115,228 (19.5%)

Largest asset managers voting on “Election of three Class II directors for three-year terms: Thomas Malley” at KURA ONCOLOGY INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	4,858,902	0	For
BlackRock	3,761,831	0	For
Fidelity	1,638,027	800	For
State Street	3,924	1,616,574	Abstain
FRANKLIN STRATEGIC SERIES	761,091	0	For
Dimensional	0	684,977	Abstain
Charles Schwab	622,972	0	For
TIAA	233,167	0	For
Equitable	117,367	83,100	For
Exchange Place Advisors Trust	193,488	0	For
Prudential/PGIM	134,347	11,055	For
QUANTITATIVE MASTER SERIES LLC	125,392	0	For
Lincoln Financial	23,647	100,844	Abstain
Putnam	95,013	0	For
PACE SELECT ADVISORS TRUST	0	72,226	Abstain
American Century	0	68,322	Abstain
MASTER INVESTMENT PORTFOLIO	62,429	0	For
Northern Trust	0	47,274	Abstain
Brighthouse	0	46,193	Abstain
Direxion Shares ETF Trust	0	44,590	Abstain
ProShares	0	44,546	Abstain
Global X	43,592	0	For
Voya	0	39,685	Abstain
PFM Multi-Manager Series Trust	0	39,024	Abstain
Harbor ETF Trust	37,944	0	For

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.

6. RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2025-06-05.

99.8% Majority: yes · of votes cast

FOR 99.8%

FOR: 70,490,630AGAINST: 72,936

KURA ONCOLOGY INC.’s own tally for this item (“Proposal 2. Ratification of the Appointment of Independent Registered Public Accounting Firm”): 70,490,630 for, 72,936 against, per its Form 8-K filed 2025-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 80,778,000 outstanding shares: 87% for, 0.1% against (87% of the company cast a for/against vote).

The 56 asset managers below cast 99.9% of the shares they voted on this item FOR (15,955,716 for, 64 against).

FOR 99.9%

FOR: 15,955,716 (99.9%)AGAINST: 64 (0.0%)ABSTAIN: 8,319 (0.1%)

Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ” at KURA ONCOLOGY INC., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	4,858,902	0	0	For
BlackRock	3,761,831	0	0	For
Fidelity	1,638,827	0	0	For
State Street	1,620,434	64	0	For
FRANKLIN STRATEGIC SERIES	761,091	0	0	For
Dimensional	684,977	0	0	For
Charles Schwab	622,972	0	0	For
TIAA	233,167	0	0	For
Equitable	200,467	0	0	For
Exchange Place Advisors Trust	193,488	0	0	For
Prudential/PGIM	145,402	0	0	For
QUANTITATIVE MASTER SERIES LLC	125,392	0	0	For
Lincoln Financial	124,491	0	0	For
Putnam	95,013	0	0	For
PACE SELECT ADVISORS TRUST	72,226	0	0	For
American Century	68,322	0	0	For
MASTER INVESTMENT PORTFOLIO	62,429	0	0	For
Northern Trust	47,274	0	0	For
Brighthouse	37,874	0	8,319	For
Direxion Shares ETF Trust	44,590	0	0	For
ProShares	44,546	0	0	For
Global X	43,592	0	0	For
Voya	39,685	0	0	For
PFM Multi-Manager Series Trust	39,024	0	0	For
Harbor ETF Trust	37,944	0	0	For

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.

7. Approval, on an advisory basis, of the compensation of our named executive officers during the year ended December 31, 2023.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2024-06-05 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%8%

FOR: 61,538,693AGAINST: 5,449,767

KURA ONCOLOGY INC.’s own tally for this item (“Proposal 3. Advisory Vote on Executive Compensation”): 61,538,693 for, 5,449,767 against, per its Form 8-K filed 2024-06-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 80,778,000 outstanding shares: 76% for, 7% against (83% of the company cast a for/against vote).

The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 92 against).

AGAINST 100%

AGAINST: 92 (100.0%)

Largest asset managers voting on “Approval, on an advisory basis, of the compensation of our named executive officers during the year ended Dece” at KURA ONCOLOGY INC., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
COLDSTREAM CAPITAL MANAGEMENT INC	0	92	0	0	Against
Echo45 Advisors LLC	0	0	0	0	--

Largest KURA ONCOLOGY INC. shareholders voting in 2024-2025

Ranked by the number of KURA ONCOLOGY INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 80,778,000 shares outstanding at the time of that meeting.

Top KURA ONCOLOGY INC. shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	BVF INC/IL	9.60%
2	SUVRETTA CAPITAL MANAGEMENT, LLC	9.23%
3	BlackRock	9.10%
4	ARMISTICE CAPITAL, LLC	7.46%
5	Vanguard	6.24%
6	State Street	5.84%
7	RA CAPITAL MANAGEMENT, L.P.	4.90%
8	GEODE CAPITAL MANAGEMENT, LLC	2.24%
9	Fidelity	2.04%
10	FRANKLIN ADVISERS INC	1.69%

Reported KURA ONCOLOGY INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

KURA ONCOLOGY INC. beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
BVF PARTNERS L P/IL	10.74%	13G
BlackRock	10.12%	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	9.36%	13G
Vanguard Group	6.13%	13F
RA Capital Management, L.P.	5.41%	DEF14A
EcoR1 Capital, LLC	5.20%	13G
Armistice Capital, LLC	4.63%	13G
State Street	4.06%	13F
Troy E. Wilson, Ph.D., J.D.	3.48%	DEF14A
Morgan Stanley	2.38%	13F

Percentages above are of 80,778,000 shares outstanding, as reported by KURA ONCOLOGY INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from KURA ONCOLOGY INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At KURA ONCOLOGY INC.'s shareholder meeting held 2025-06-05, in the 2024-2025 proxy season, 184 asset managers reported how they voted on 7 ballot items in their SEC Form N-PX filings, covering 1,226 separate fund positions. On the most widely held item on that ballot — Approval, on an advisory basis, of the compensation of our named executive officers, as… — FOR was 98% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: KURA ONCOLOGY INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-06.

KURA ONCOLOGY INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.